1. Home
  2. JAZZ vs PKX Comparison

JAZZ vs PKX Comparison

Compare JAZZ & PKX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

N/A

Current Price

$242.66

Market Cap

16.1B

Sector

Health Care

ML Signal

N/A

Logo POSCO Holdings Inc.

PKX

POSCO Holdings Inc.

N/A

Current Price

$48.45

Market Cap

15.0B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
JAZZ
PKX
Founded
2003
1968
Country
Ireland
South Korea
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Steel/Iron Ore
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
16.1B
15.0B
IPO Year
2007
1998

Fundamental Metrics

Financial Performance
Metric
JAZZ
PKX
Price
$242.66
$48.45
Analyst Decision
Buy
Analyst Count
22
0
Target Price
★ $297.50
N/A
AVG Volume (30 Days)
★ 691.1K
242.1K
Earning Date
11-02-2026
11-02-2026
Dividend Yield
N/A
★ 2.50%
EPS Growth
N/A
★ N/A
EPS
★ 0.04
N/A
Revenue
★ $1,618,693,000.00
N/A
Revenue This Year
$12.68
$7.35
Revenue Next Year
$5.34
$2.43
P/E Ratio
$6,014.25
★ $42.95
Revenue Growth
N/A
N/A
52 Week Low
$156.95
$47.63
52 Week High
$266.38
$92.40

Technical Indicators

Market Signals
Indicator
JAZZ
PKX
Relative Strength Index (RSI) 61.11 39.02
Support Level $236.70 N/A
Resistance Level $250.49 $59.26
Average True Range (ATR) 7.43 1.26
MACD 2.04 0.03
Stochastic Oscillator 81.96 14.82

Price Performance

Historical Comparison
JAZZ
PKX

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

About PKX POSCO Holdings Inc.

POSCO Holdings Inc is a holding company operating through its subsidiaries. Its business is divided into segments, with the Steel segment generating the majority of revenue from the manufacture and sale of steel products. The Infrastructure segment includes trading, construction, and logistics and system integration activities. The Rechargeable Battery Materials segment focuses on EV battery materials such as lithium, nickel, and cathode and anode materials. The Others segment includes the controlling company and investment business. Geographically, the Group generates majority of its revenue from Asia (excluding China and Japan).

Share on Social Networks: